Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

New Dow Jones Credit Suisse Hedge Fund Index commentary offers insight into January hedge fund performance

Thursday, March 01, 2012
Opalesque Industry Update: The Dow Jones Credit Suisse Hedge Fund Index finished up 2.34% in January. A new monthly commentary offers insight into hedge fund performance through the month of January. Some key findings from the report include:

  • Hedge funds, as measured by the Dow Jones Credit Suisse Hedge Fund Index, finished January up 2.34%; with 9 out of 10 strategies in positive territory;
  • In total, the industry saw estimated outflows of approximately $15 billion in January, bringing overall assets under management for the industry to approximately $1.72 trillion;
  • The Equity Market Neutral and Convertible Arbitrage sectors experienced the largest asset inflows on a percentage basis in January, with inflows of 2.27% and 0.87% from December 2011 levels, respectively;
  • Directional strategies, such as Long/Short Equity, experienced positive performance driven by a risky asset rally. Mean reversion was a notable trend as sectors that performed poorly for the year in 2011 performed well in January;
  • Tactical trading managers showed generally positive performance. Global Macro managers and Managed Futures funds posted gains as managers benefitted from macroeconomic shifts; and
  • On the relative value front, managers showed positive performance in January. Fixed Income Arbitrage managers posted gains despite the swift change from a risk-off to a risk-on market.

Read the full report here.

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for